| Title |
Compliance with quality prescribing indicators in terms of their relationship to financial incentives
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, June 2013
|
| DOI | 10.1007/s00228-013-1542-4 |
| Pubmed ID | |
| Authors |
Rocío Fernández Urrusuno, Ma Carmen Montero Balosa, Pastora Pérez Pérez, Beatriz Pascual de la Pisa |
| Abstract |
To develop quality prescribing indicators for general practitioners (GPs) who are non-monitored and not included in pay-for-performance programs, and to determine compliance with incentivized and non-incentivized indicators. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 83% |
| Unknown | 1 | 17% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Ireland | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 95 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 26 | 27% |
| Researcher | 15 | 15% |
| Student > Ph. D. Student | 9 | 9% |
| Student > Bachelor | 8 | 8% |
| Student > Postgraduate | 6 | 6% |
| Other | 16 | 16% |
| Unknown | 18 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 31 | 32% |
| Nursing and Health Professions | 10 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 9% |
| Business, Management and Accounting | 7 | 7% |
| Social Sciences | 6 | 6% |
| Other | 15 | 15% |
| Unknown | 20 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2013.
All research outputs
#8,235,171
of 25,374,374 outputs
Outputs from European Journal of Clinical Pharmacology
#921
of 2,747 outputs
Outputs of similar age
#66,484
of 203,933 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#14
of 23 outputs
Altmetric has tracked 25,374,374 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 2,747 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,933 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.